跳至主要内容
临床试验/CTRI/2025/01/079769
CTRI/2025/01/079769已完成2/3 期

Utility of homoeopathic medical repertory by Robin murphy in the management of chronic Urticaria assessed by urticaria activity score

DR ARPITABEN RAJNIKANTBHAI PATEL1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年2月10日最近更新:

试验速览

阶段
2/3 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
URTICARIA ACTIVITY SCORE TO ASSESS REDUCTION IN URTICARIA SYMPTOMS

研究概览

简要总结

THIS STUDY IS A PROSPECTIVE STUDY PRE TEST POST TEST ONE GROUP EXPERIMENTAL STUDY TO ASSESS THE UTILITY OF HOMOEOPATHY MEDICAL REPERTORY BY ROBIN MURPHY FOR 8 MONTHS IN 40 PARTICIPANTS WITH CHRONIC URTICARIA THAT WILL BE CONDUCTED AS PER INCLUSION AND EXCLUSION CRITERIA FROM OUT PATIENT DEPARTMENT AND THE OUTCOMES MEASURES WILL BE ASSESS WITH  URTICARIA  ACTIVITY SCORE AT EVERY MONTH UPTO 8 MONTH PARTICIPANTS FOLLOW UP AT EVERY MONTH AND AS PER NEED OF CASE FOR 8 MONTHS OF DURATION

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant Blinded

入排标准

年龄范围
20.00 Year(s) 至 40.00 Year(s)(—)

入选标准

  • Age group people from 20 to 40 years age group Gender Male and Female Case presenting with symptoms of chronic urticaria Patient will be selected on the basis of clinically diagnosed characteristics of erythema and itchy lesions which is subside within 24 hour Patients who gave voluntary consent and be able to fill the Urticaria Activity Score to be included in the study Urticaria Activity Score over 1 week cases range between 7 to 27 include mild and moderate urticaria according Urticaria Activity Score.

排除标准

  • Pregnant women and lactating women were not included in the study Patient having other co morbid conditions associated with chronic urticaria such as thyroid disease inflammatory disease DM malignancy Vasculitic urticaria angioedema with no urticaria anaphylaxia Patient taking any mode of treatment like allopathic homoeopathic ayurvedic for urticaria.

结局指标

主要结局

URTICARIA ACTIVITY SCORE TO ASSESS REDUCTION IN URTICARIA SYMPTOMS

时间窗: SCORE WILL BE ASSESSED AT BASELINE AND EVERYMONTH OF TREATMENT AND AS PER REQUIREMENT OF CASES

次要结局

未报告次要终点

研究者

发起方
DR ARPITABEN RAJNIKANTBHAI PATEL
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR ARPITABEN RAJNIKANTBHAI PATEL

SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE

研究点 (1)

Loading locations...

相似试验